Results 81 to 90 of about 6,016 (111)

[Deubiquitinating enzyme MINDY1 is an independent risk factor for the maintenance of stemness and poor prognosis in liver cancer cells]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2023
Xia BL, Liu KW, Huang HX, Shen MM, Wang B, Gao J.   +5 more
europepmc   +1 more source

[Strategies for liver injury caused by hepatocellular carcinoma targeted therapy]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2023
Zhao SX, Liu SH, Nan YM.
europepmc   +1 more source

SREBPs及其在肝细胞癌中的作用机制研究进展

Zhongguo shiyan zhenduanxue
肝细胞癌（hepatocellular carcinoma, HCC）在全球原发性肝癌中占比超过80%,给健康带来沉重的负担，被认为是全球癌症相关死亡的第四大常见原因[1]。肝癌病例数量的不断增加不仅与人口老龄化相关，在过去20年中，与肥胖相关的脂肪性肝病的逐渐增加也加剧了肝癌病例总数的增长。值得注意的是，快速上升的非酒精性脂肪性肝病（nonalcoholic fatty liver disease, NAFLD ...
陈雨恒, 吕凌
doaj  

[Factors affecting tumorigenicity in liver cancer xenografts]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Chai MY, Dou SS, Kou BX, Huo YF, Gao MH, Li QW, Liu XN.   +6 more
europepmc   +1 more source

[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zou J, Wang H, Zhang D.
europepmc   +1 more source

[Novel research horizon for liver transplantation management model in hepatocellular carcinoma based on the tumor-donor liver-recipient]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Xu SJ, Xu YY, Xu X.
europepmc   +1 more source

[<i>Yiqi Jiedu</i> Formula regulates immune microenvironment of liver cancer in mice by inhibiting overactivation of NF-κB signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Z, Liu L, Shi M, Hou Y, Dong L, Zhang G.   +5 more
europepmc   +1 more source

[Chinese expert guidance on overall application of lenvatinib in hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2023
Yang XR, Sun HC, Xie Q, Zhang WG, Jia WD, Zhao M, Zhao HT, Liu XF, Zhou LD, Yan S, Xu L, Wang NY, Ding Y, Zhu XD, Zhou J, Fan J.   +15 more
europepmc   +1 more source

[Establishment of a database for liver cancer ablation and its clinical research value]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Luo YC, Lang ML, Liang P, Yu J.
europepmc   +1 more source

Rel mRNA 和 NF- κB2 mRNA 在人肝细胞癌中的表达及其临床意义

Zhongshan Daxue xuebao. Yixue kexue ban, 2006
【目的】探讨 Rel 及 NF- κB2 的 mRNA 在人肝细胞癌( hepatocellular carcinoma, HCC) 组织中的表达及其临床意义。【方法】 用逆转录聚合酶链反应检测 55 例 HCC 患者癌组织及癌旁肝组织中 Rel mRNA 和NF- κB2 mRNA 的表达情况。【结果】Rel mRNA 及 NF- κB2 mRNA 在肝癌组织中的表达水平均明显低于其癌旁组织( 分别为 0.315±0.142 对 0.505±0.225; 0.273±0.141 对 0.491±0 ...
doaj